[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370625-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-370625-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","prognostic-value-of-the-triglyceride-glucose-index-in-gastric-cancer-letter-to-the-editor","Prognostic value of the triglyceride-glucose index in gastric cancer - Letter to the Editor","","Advanced gastric cancer remains a high-mortality malignancy despite diagnostic and therapeutic progress, including immunotherapy. Reliable prognostic markers are needed for better patient stratification. The triglyceride-glucose (TyG) index, proposed as an insulin-resistance marker, has shown value in multiple cancers, yet its prognostic relevance in gastric cancer is uncertain. This letter reviews evidence on TyG and discusses potential implications for prognosis and treatment strategies.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-value-of-the-triglyceride-glucose-index-in-gastric-cancer-letter-to-the-editor/370625/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-value-of-the-triglyceride-glucose-index-in-gastric-cancer-letter-to-the-editor/370625.png","ImageObject",300,407,{"name":42,"@type":43},"วิน","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":26},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the triglyceride-glucose (TyG) index and why is it relevant to gastric cancer?","Question",{"text":62,"@type":63},"The TyG index combines fasting plasma glucose and triglyceride levels as a noninvasive surrogate marker of insulin resistance. It is considered potentially informative for prognosis in gastric cancer, though its role has been unclear.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Why are prognostic markers important in advanced gastric cancer?",{"text":67,"@type":63},"Advanced gastric cancer carries high mortality, and treatment responses vary among patients. Prognostic markers support better patient stratification and more appropriate clinical decision-making.",{"name":69,"@type":60,"acceptedAnswer":70},"How does insulin resistance relate to cancer development mentioned in the document?",{"text":71,"@type":63},"Insulin resistance can promote chronic inflammation and influence signaling pathways that affect cell proliferation and apoptosis. It is also discussed as a key mechanism within metabolic syndrome-associated gastric carcinogenesis.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},370625,1790189520,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":26,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":96,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":79,"read_time":143,"preview_page_count":33,"preview_urls":144},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","| W | J | G | World Journal of\u003Cbr>Gastroenterology |\n| --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com)  \n[DOI:](DOI: 10.3748/wjg.v31.i17.104651)[ 10.3748/wjg.v31.i17.104651](DOI: 10.3748/wjg.v31.i17.104651)  \nWorld J Gastroenterol 2025 May 7; 31(17): 104651 ISSN 1007-9327 (print) ISSN 2219-2840 (online)  \nLETTER TO THE EDITOR  \nPrognostic value of the triglyceride-glucose index in gastric cancer  \nTugce Eskazan, Suat Saribas, Bekir Kocazeybek  \nSpecialty type: Gastroenterology and hepatology  \nProvenance and peer review:  \nInvited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade C, Grade C, Grade C  \nNovelty: Grade B, Grade C, Grade C  \nCreativity or Innovation: Grade B, Grade C, Grade C  \nScientific Significance: Grade B, Grade B, Grade C  \nP-Reviewer: Haque MA; Zhang JZ  \nReceived: December 27, 2024  \nRevised: March 4, 2025  \nAccepted: March 21, 2025  \nPublished online: May 7, 2025  \nProcessing time: 123 Days and 20.8 Hours  \nTugce Eskazan, Department of Internal Medicine, İstanbul University Cerrahpaşa Faculty of Medicine, İstanbul 34640, Türkiye  \nSuat Saribas, Bekir Kocazeybek, Department of Medical Microbiology, Istanbul University  \nCerrahpasa, Cerrahpasa Medical Faculty, Istanbul 34098, Türkiye Co-first authors: Tugce Eskazan and Suat Saribas.  \nCorresponding author: Bekir Kocazeybek, Professor, Department of Medical Microbiology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Kocamustafapaşa St No. 53, Istanbul 34098, Tü[rkiye.](rkiye. bzeybek@istanbul.edu.tr)[ bzeybek@istanbul.edu.tr](rkiye. bzeybek@istanbul.edu.tr)  \nAbstract  \nAdvanced gastric cancer (GC) remains a high-mortality malignancy despite progress in diagnosis and treatment, including immunotherapy. Reliable prognostic markers are essential for better patient stratification. The triglycerideglucose (TyG) index, a marker of insulin resistance, has shown promise in various cancers, but its role in GC remains unclear. Yao et al investigated its prognostic value in 300 patients with advanced GC receiving immunotherapy and chemotherapy. Their model, which integrates the TyG index, programmed death-ligand 1 expression, and Eastern Cooperative Oncology Group performance status, underscores the impact of metabolic dysfunction on immune response and treatment efficacy. This letter examines the TyG index’s potential as a prognostic tool in GC and its implications for treatment strategies guided by metabolic and immune factors, as demonstrated in Yao et al research.  \nKey Words: Gastric cancer; Immunotherapy; Immune response; Prognosis; Triglycerideglucose index  \n©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.  \nCore Tip: Gastric cancer (GC) remains a high-mortality malignancy despite advances in diagnostics and treatments. Histopathological and biochemical markers that predict prognosis are crucial for treatment planning and assessing mortality and morbidity risk. Recent studies highlight the prognostic value of the triglyceride-glucose ratio (an indirect indicator of insulin resistance) in various cancer types. However, a deeper understanding of its role in predicting the immunotherapy response in GC is critically needed.  \n WJG  [https://www.wjgnet.com](https://www.wjgnet.com) 1 May 7, 2025  Volume 31  Issue 17   \nEskazan T et al. TyG Index in GC  \nCitation: Eskazan T, Saribas S, Kocazeybek B. Prognostic value of the triglyceride-glucose index in gastric cancer. World JGastroenterol 2025; 31(17): 104651  \nURL: [https://www.wjgnet.com/1007-9327/full/v31/i17/104651.htm](https://www.wjgnet.com/1007-9327/full/v31/i17/104651.htm)  \nDOI: [https://dx.doi.org/10.3748/wjg.v31.i17.104651](https://dx.doi.org/10.3748/wjg.v31.i17.104651)  \nThe link between metabolic syndrome and cancer has received increasing attention in recent years. Its impact on cancer development is complex and","cbCairfZ24L6wfUi","https://ap.wps.com/l/cbCairfZ24L6wfUi","pdf",369485,"English","# Abstract\n# Key Words\n# Core Tip\n# Introduction and Background\n# Metabolic Syndrome and Cancer Link\n# Insulin Resistance and Gastric Cancer Risk Factors\n# Triglyceride-Glucose (TyG) Index as a Marker\n# Citations and Publication Details","[{\"question\":\"What is the triglyceride-glucose (TyG) index and why is it relevant to gastric cancer?\",\"answer\":\"The TyG index combines fasting plasma glucose and triglyceride levels as a noninvasive surrogate marker of insulin resistance. It is considered potentially informative for prognosis in gastric cancer, though its role has been unclear.\"},{\"question\":\"Why are prognostic markers important in advanced gastric cancer?\",\"answer\":\"Advanced gastric cancer carries high mortality, and treatment responses vary among patients. Prognostic markers support better patient stratification and more appropriate clinical decision-making.\"},{\"question\":\"How does insulin resistance relate to cancer development mentioned in the document?\",\"answer\":\"Insulin resistance can promote chronic inflammation and influence signaling pathways that affect cell proliferation and apoptosis. It is also discussed as a key mechanism within metabolic syndrome-associated gastric carcinogenesis.\"}]","Prognostic value of the triglyceride-glucose index in gastric cancer - Letter to the Editor | PDF",13,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7e2546046b41ef8dbadb0adb4b7606d6.webp",983,1390,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6215e3ed2c18986b82e48e14f026cbb.webp",982,1389,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e1ddec7dd0a29d5599c4479b27f21e0.webp",981,1387,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d55a8841eef5359cbcce3a5051969bd1.webp",980,1386]